Dr. Agarwal's Eye Hospital Limited (BOM:526783)
India · Delayed Price · Currency is INR 5,373.85
+63.85 (1.20%)
At close: Aug 21, 2026
BOM:526783 Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 4,969 | 4,709 | 3,972 | 3,193 | 2,681 | 2,012 |
Revenue Growth | 20.01% | 18.56% | 24.38% | 19.10% | 33.24% | 43.39% |
Gross Profit Gross Profit Growth | 2,288 | 2,116 | 1,712 | 1,325 | 1,105 | 1,363 |
Operating Income Operating Income Growth | 1,049 | 996.7 | 792.1 | 646.8 | 548.3 | 372.9 |
Net Income Net Income Growth | 762.2 | 701 | 546.5 | 463.6 | 369.2 | 241 |
Earnings Per Share EPS Growth | 158.76 | 147.02 | 116.28 | 98.64 | 78.55 | 51.28 |
EPS Growth | 29.09% | 26.44% | 17.88% | 25.57% | 53.19% | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 957.7 | 956.9 | 228.7 | 328.8 | 273.8 | 281.1 |
Total Debt Total Debt Growth | 3,261 | 3,261 | 3,332 | 2,680 | 2,325 | 1,935 |
Net Cash (Debt) Net Cash Growth | -2,304 | -2,304 | -3,103 | -2,351 | -2,051 | -1,654 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -479.81 | -483.30 | -660.19 | -500.30 | -436.36 | -351.81 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,451 | 935.6 | 897.7 | 696.2 | 566.8 |
Capital Expenditures CapEx Growth | - | -983.9 | -1,029 | -713.2 | -703.4 | -467.3 |
Free Cash Flow Free Cash Flow Growth | - | 467.5 | -93 | 184.5 | -7.2 | 99.5 |
Free Cash Flow Growth | - | - | - | - | - | -56.15% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 46.04% | 44.94% | 43.11% | 41.50% | 41.21% | 67.73% |
Operating Margin | 21.11% | 21.17% | 19.95% | 20.26% | 20.45% | 18.53% |
Pretax Margin | 20.40% | 19.88% | 17.80% | 19.50% | 18.43% | 16.06% |
Profit Margin | 15.34% | 14.89% | 13.76% | 14.52% | 13.77% | 11.98% |
FCF Margin | - | 9.93% | -2.34% | 5.78% | -0.27% | 4.95% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 7.000 | 7.000 | 6.000 | 5.000 | 3.000 | 3.000 |
Dividend Per Share Growth | -38.46% | 16.67% | 20.00% | 66.67% | 0% | - |
Dividend Yield | 0.13% | 0.15% | 0.15% | 0.16% | 0.33% | 0.41% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.85 | 32.40 | 34.85 | 31.46 | 11.65 | 14.26 |
P/FCF Ratio | 55.55 | 48.58 | - | 79.06 | - | 34.53 |
PS Ratio | 5.23 | 4.82 | 4.80 | 4.57 | 1.61 | 1.71 |